Spero Therapeutics to Present at March Investor Conferences
Mar 01, 2018 13:02 pm UTC| Business
CAMBRIDGE, Mass., March 01, 2018 -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for...
FDA Accepts REMOXY® NDA for Review, Sets PDUFA Date of August 7, 2018
Mar 01, 2018 13:02 pm UTC| Business
AUSTIN, Texas, March 01, 2018 -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today that the U.S. Food and Drug Administration (FDA) has determined that a New Drug Application (NDA) for REMOXY ER, the Company’s lead...
QuarkXPress 2018 is Coming May 16, 2018
Mar 01, 2018 13:02 pm UTC| Business
Denver, CO, March 01, 2018 -- Quark announced today the upcoming availability of QuarkXPress 2018, the next new full version of Quark’s graphic design and page layout software. Coming on May 16, 2018, QuarkXPress 2018...
Compelling lab results, Lithium solution bench testing up next
Mar 01, 2018 13:02 pm UTC| Business
KELOWNA, British Columbia, March 01, 2018 -- via NetworkWire – Enertopia Corporation (OTCQB:ENRT) (CSE:TOP) (the "Company" or "Enertopia") is pleased to announce the following updates for the recovery of Lithium and...
FTE Closes 3-Year Deal With Production Company for Leading Entertainment Outlet
Mar 01, 2018 13:01 pm UTC| Business
NAPLES, Fla., March 01, 2018 -- FTE Networks, Inc. (NYSE American:FTNW) ("FTE" or the "Company"), a leading provider of innovative technology-oriented solutions for smart platforms, network infrastructure and...
Consolidated Communications Reports Fourth Quarter 2017 Results
Mar 01, 2018 13:01 pm UTC| Business
Declared 51st consecutive quarterly dividendGrew commercial and carrier data and transport revenue 1.4 percentFairPoint integration on target to achieve $55 million in synergiesAnnounced plans to expand fiber network...
scPharmaceuticals Inc. to Present at the Cowen 38th Annual Health Care Conference
Mar 01, 2018 13:01 pm UTC| Business
BURLINGTON, Mass., March 01, 2018 -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused therapies, advance...